Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive;Cerca de metade dos pacientes brasileiros recebendo natalizumabe para tratamento de esclerose múltipla tem DNA-JC vírus positivo

Arquivos de Neuro-Psiquiatria

Volumn 71, Issue 10, 2013, Pages 780-782

  Fragoso, Yara Dadalti ^a   Mendes, Maria Fernanda ^b   Arruda, Walter Oleschko ^c   Becker, Jefferson ^d   Brooks, Joseph Bruno Bidin ^a   Carvalho, Margarete de Jesus ^e   Comini Frota, Elizabeth Regina ^f   Domingues, Renan Barros ^g   Ferreira, Maria Lucia Brito ^h   Finkelsztejn, Alessandro ⁱ   da Gama, Paulo Diniz ^j   Gomes, Sidney ^k   Gonçalves, Marcus Vinicius Magno ^l   Kaimen Maciel, Damacio Ramon ^m   Morales, Rogério de Rizo ⁿ   Muniz, Andre ^o   Ruocco, Heloisa Helena ^p   Salgado, Pedro Rippel ^q   de Albuquerque, Livia Brito Bezerra ^h   da Gama, Rodrigo Assad Diniz ^j   Georgeto, Sergio ^m   Lopes, Josiane ^m   Oliveira, Celso Luis Silva ^a   Oliveira, Francisco Tomaz Meneses ^k   Safanelli, Juliana ^l   Saldanha, Patricia Correia de Oliveira ^g   Satomi, Massaco ^q   more..

^a UNIVERSIDADE METROPOLITANA DE SANTOS   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e Nursing School at ABC Foundation   (Brazil)

^f FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^g Santa Casa of Vitoria Hospital   (Brazil)

^h HOSPITAL DA RESTAURAÇÃO   (Brazil)

ⁱ HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^j PONTIFÍCIA UNIVERSIDADE CATÓLICA DE SÃO PAULO   (Brazil)

^k HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

^l UNIVERSITY OF JOINVILLE REGION   (Brazil)

^m STATE UNIVERSITY OF LONDRINA   (Brazil)

ⁿ FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^o HOSPITAL SÃO RAFAEL   (Brazil)

^p Multiple Sclerosis Center of Jundiaí   (Brazil)

^q FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

more..

Author keywords

JC virus; Multifocal leukoencephalopathy; Multiple sclerosis; Natalizumab

Indexed keywords

BETA INTERFERON; GLATIRAMER; NATALIZUMAB; VIRUS DNA;

ADULT; ARTICLE; DNA VIRUS INFECTION; DRUG TREATMENT FAILURE; FEMALE; HUMAN; JC VIRUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; REAL TIME POLYMERASE CHAIN REACTION; VIREMIA; VIRUS DETECTION;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; BRAZIL; DNA, VIRAL; FEMALE; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 84887146422     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20130121     Document Type: Article

References (11)

1. Dutta R, Trapp BD. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 2011;93:1-12.
2. Rudick R, Polman C, Clifford D, Miller D, Steinman L. Natalizumab: bench to bedside and beyond. Arch Neurol 2012;5:1-11.
3. Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, Corboy J, Vollmer T. Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab. J Neuropathol Exp Neurol 2012;71:604-617.
4. Sørensen PS, Bertolotto A, Edan G, et al. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Mult Scler 2012;18:143-152.
5. Berger JR, Houff S. Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol Res 2006;28:299-305.
6. Khalili K, White MK, Lublin F, Ferrante P, Berger JR. Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology 2007;68:985-990.
7. Trampe AK, Hemmelmann C, Stroet A, et al. Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort. Neurology 2012;78:1736-1742.
8. Outteryck O, Ongagna JC, Duhamel A, et al. Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy. J Neurol 2012;259:2293-2298.
9. Berger JR, Houff SA, Gurwell J, Vega N, Miller CS, Danaher RJ. JC virus antibody status underestimates infection rates. Ann Neurol 2013 Mar 22 [E-pub].
10. Mazda ME, Brosch JR, Wiens AL, et al. A case of natalizumabassociated progressive multifocal leukoencephalopathy with repeated negative CSF JCV testing. Int J Neurosci 2013;123:353-357.
11. Fragoso YD, Alves-Leon SV, Arruda WO, et al. Natalizumab adverse events are rare in patients with multiple sclerosis. Arq Neuropsiquiatr 2013;71:137-141.